Loss of Payload Sensitivity and Other Mechanisms of Resistance to T-DXd in HER2-Mutant NSCLC: Implications for Subsequent Responsiveness to HER2 TKIs
The University of Texas MD Anderson Cancer Center · Stanford Medicine · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
4
total citations
- FWCI
- 51.75
- Percentile
- 99%
- References
- 49
Too recent for citation history.
Authors
32- MBMonique B. NilssonCorresponding
The University of Texas MD Anderson Cancer Center
- XLXiuning Le
The University of Texas MD Anderson Cancer Center
- APAlissa Poteete
The University of Texas MD Anderson Cancer Center
- XYXiaoxing Yu
The University of Texas MD Anderson Cancer Center
- JHJunqin He
The University of Texas MD Anderson Cancer Center
Topics & keywords
Topics
Keywords
- Sensitivity (control systems)
- Mechanism (biology)
- Payload (computing)
- Acquired resistance
- Drug resistance
No related works found for this paper.
Funding
- LRLymphoma Research Foundation
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- BBayer
- GGlaxoSmithKline
- SSanofi
- CPCancer Prevention and Research Institute of TexasAward: RP250322
- GSGilead Sciences
- SPSpectrum Pharmaceuticals
- VMVarian Medical Systems
- HHelsinn
- RPRegeneron Pharmaceuticals
- MKMerck KGaA
- JPJazz Pharmaceuticals
- NNovocure
- AAccuray
- MTMirati Therapeutics
- BBeiGene
- IBInnovent Biologics
- SSeagen
- RFRexanna's Foundation
- GGenentech
- ESEMD Serono
- CPChugai Pharmaceutical
- ELEli Lilly Japan
- NCNational Cancer Institute
- JPJanssen Pharmaceuticals
- TWTroper Wojcicki Foundation